The 2-Minute Rule for PF-07258669
We thank this reviewer for his or her feed-back and recognition that DNL343 provides a promising likely as therapy for neurodegenerative disorders. Although our research share some similarities to Wong et al., eLifeDNL343 is an investigational CNS-penetrant smaller molecule ISR inhibitor made to activate the eukaryotic initiation component 2B (eIF2